about
Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: formation of aggregates and higher-order complexes.Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray.Comparison of topical 0.7% dexamethasone-cyclodextrin with 0.1% dexamethasone sodium phosphate for postcataract inflammation.Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye.Cyclodextrins in drug delivery.Clinical trial: marine lipid suppositories as laxatives.Assessment of mucoadhesion by a resonant mirror biosensor.Cyclodextrins and their pharmaceutical applications.Cyclodextrins as pharmaceutical solubilizers.Effects of cyclodextrins on drug delivery through biological membranes.Physicochemical properties of water and its effect on drug delivery. A commentary.Self-assembled cyclodextrin aggregates and nanoparticles.Pharmaceutical applications of cyclodextrins: basic science and product development.Topical drug delivery to the eye: dorzolamide.Cyclodextrins as functional excipients: methods to enhance complexation efficiency.Cyclodextrin-based nanogels for pharmaceutical and biomedical applications.Encapsulation of drug molecules into calix[n]arene nanobaskets. role of aminocalix[n]arenes in biopharmaceutical field.Diffusion characteristics of vitreous humour and saline solution follow the Stokes Einstein equation.Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.Parenteral delivery of HPβCD: effects on drug-HSA binding.Carvedilol: solubilization and cyclodextrin complexation: a technical note.Evaluation of a cationic calix[4]arene: Solubilization and self-aggregation ability.Effects of cogrinding with β-cyclodextrin on the solid state fentanyl.Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension.Cyclodextrins as solubilizers: formation of complex aggregates.Hydrolysis kinetics and QSAR investigation of soft antimicrobial agents.A permeation method for detection of self-aggregation of doxorubicin in aqueous environment.For the special IJP issue "poorly soluble drugs".Cyclodextrins and drug permeability through semi-permeable cellophane membranes.Self-assembly of cyclodextrins: the effect of the guest molecule.Dextran-based cyclodextrin polymers: their solubilizing effect and self-association.Cycloserine fatty acid derivatives as prodrugs: synthesis, degradation and in vitro skin permeability.Buccal absorption of ergotamine tartrate using the bioadhesive tablet system in guinea-pigs.Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability.Self-association and cyclodextrin solubilization of drugs.Examination of 19F-NMR as a tool for investigation of drug-cyclodextrin complexes.The effects of organic salts on the cyclodextrin solubilization of drugs.Cyclodextrin formulation of dorzolamide and its distribution in the eye after topical administration.Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes.The effect of parenterally administered cyclodextrins on the pharmacokinetics of coadministered drugs.
P50
Q30989482-282D096A-DC2F-4617-BD31-4DA62DF091C8Q31880580-41ABCE87-0376-4E1F-B826-FE98F7AEBB38Q33224966-80701E7F-7DF8-42E7-B9C8-DB152BFE9503Q34600427-95234965-22AC-4F37-9E69-60C975D753F3Q36316735-B1291971-E583-423F-90BC-6035A194B423Q36329877-58FE1953-0566-4DAB-821C-B355178E7DA8Q36564181-8440F38D-46C5-4DC5-A5E6-597F3D31686EQ36669786-BA079F5D-F9FC-4667-9EE8-D766CEABF42DQ36865281-9ABC9D3F-C3CF-42E1-82DC-0286EF6995FCQ36881370-4F1FBFE5-FC8B-40D9-90E4-66A5A5E22856Q36963342-8E1E64C6-AD89-4595-B52F-726D8404A182Q37645000-589E19C8-1B5C-4E04-A51B-2748992483A2Q37805590-CD256AF8-FEB2-4088-8E59-C3F3887FB6C5Q37978007-0D49B954-4D02-4F58-93D0-0800337CD4BAQ37984024-DEE298C8-B5ED-4C3F-9B76-311192C5452BQ37990341-60A92F7E-DBA4-4092-825C-B0306E67D73FQ38127397-A99A936A-6EE6-43B3-9931-9530D22A1B6CQ39894881-8908433B-89CA-4747-BF74-5E9D07AED249Q41192883-5A038337-DF38-4900-B189-CD750D177B21Q41898234-CB72EC42-0DC6-46AA-AA77-B0E5E4716A6BQ42374191-605F75AA-1B82-4C40-A428-D134C9E0BC63Q42880691-8B3DC244-ECEC-4752-A93E-C97245683AD7Q42915642-A1CDBC11-D1D1-4833-B642-8FB0D147235BQ42967546-7ED0E349-BE6A-44E8-97AF-924FBD13AEE5Q43294251-DDEC7879-BDB8-4767-9E82-5E1DF36BD6BFQ43323285-C8C8ACFD-D4D0-448A-878F-661F1A7E3473Q43432077-525C175F-4AE7-4F2B-BE88-EE3886C200E9Q43447130-B7EEF046-8C88-4463-AE42-3DB84F355C1EQ43854153-73BBFEDA-CA1F-4CCA-B37F-5FB5804806ADQ43897511-3D7DCBF7-CAEF-404F-B727-856F98800FCDQ43908680-1B385B4C-D6DA-41A1-B49A-92BD7BD8E975Q43965984-B9DF349F-02F8-4C71-9BB1-941CF1C481AAQ43983922-767C618B-F8BF-4128-9FC2-21BD900491C5Q44120619-EB246EF6-F915-4887-987E-DDD864835A3BQ44179379-666176E6-FA88-4B31-A57C-45339A455951Q44325555-37D369BB-6EF7-4C63-8D5F-C53E8F7B0CB4Q44555157-C5D16AC9-F92A-471C-A2FB-32CED30DA54EQ45226216-C19F0F0F-C3A8-48B5-8C59-DBA112D85551Q45327046-183FBF1D-E93F-457B-8839-3C2FC0FCC90BQ45337688-4CD02E51-BCED-4E40-8973-830DBCAA880B
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Thorsteinn Loftsson
@ast
Thorsteinn Loftsson
@en
Thorsteinn Loftsson
@es
Thorsteinn Loftsson
@nl
Thorsteinn Loftsson
@sl
type
label
Thorsteinn Loftsson
@ast
Thorsteinn Loftsson
@en
Thorsteinn Loftsson
@es
Thorsteinn Loftsson
@nl
Thorsteinn Loftsson
@sl
prefLabel
Thorsteinn Loftsson
@ast
Thorsteinn Loftsson
@en
Thorsteinn Loftsson
@es
Thorsteinn Loftsson
@nl
Thorsteinn Loftsson
@sl
P214
P244
P106
P1153
7006889730
P21
P214
P244
no2014115560
P31
P496
0000-0002-9439-1553
P7859
lccn-no2014115560